Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 2;3(2):e000285.
doi: 10.1136/esmoopen-2017-000285. eCollection 2018.

Global cancer control: responding to the growing burden, rising costs and inequalities in access

Gerald W Prager  1 , Sofia Braga  2 , Branislav Bystricky  3 , Camilla Qvortrup  4 , Carmen Criscitiello  5 , Ece Esin  6 , Gabe S Sonke  7 , Guillem Argilés Martínez  8 , Jean-Sebastian Frenel  9 , Michalis Karamouzis  10 , Michiel Strijbos  11 , Ozan Yazici  12 , Paolo Bossi  13 , Susana Banerjee  14 , Teresa Troiani  15 , Alexandru Eniu  16 , Fortunato Ciardiello  15 , Josep Tabernero  17 , Christoph C Zielinski  18 , Paolo G Casali  19 , Fatima Cardoso  20 , Jean-Yves Douillard  21 , Svetlana Jezdic  21 , Keith McGregor  21 , Gracemarie Bricalli  21 , Malvika Vyas  21 , André Ilbawi  22
Affiliations

Global cancer control: responding to the growing burden, rising costs and inequalities in access

Gerald W Prager et al. ESMO Open. .

Abstract

The cancer burden is rising globally, exerting significant strain on populations and health systems at all income levels. In May 2017, world governments made a commitment to further invest in cancer control as a public health priority, passing the World Health Assembly Resolution 70.12 on cancer prevention and control within an integrated approach. In this manuscript, the 2016 European Society for Medical Oncology Leadership Generation Programme participants propose a strategic framework that is in line with the 2017 WHO Cancer Resolution and consistent with the principle of universal health coverage, which ensures access to optimal cancer care for all people because health is a basic human right. The time for action is now to reduce barriers and provide the highest possible quality cancer care to everyone regardless of circumstance, precondition or geographic location. The national actions and the policy recommendations in this paper set forth the vision of its authors for the future of global cancer control at the national level, where the WHO Cancer Resolution must be implemented if we are to reduce the cancer burden, avoid unnecessary suffering and save as many lives as possible.

Keywords: cancer treatment inequalities; global cancer burden; global cancer control.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AE: Currently conducting research sponsored by AstraZeneca, Pfizer, Celltrion, Novartis, Roche. JT: Advisory Boards for Amgen, Bayer, Boehringer Ingelheim, Celgene, Chugai, Genentech, Lilly, MSD, Merck Serono, Novartis, Pfizer, Roche, Sanofi, Symphogen, Taiho, and Takeda. FCi: Advisory Boards: Merck Serono, Amgen, Roche, Bayer, Lilly, Servier. Research funding: Bayer, Roche, Merck Serono. GP: Honorarium for advisory boards or speakers fee: Roche, Celgene, Shire, Merck, Amgen, Lilly, BMS, Servier, Taiho, Halozyme, Sanofi. PC: Honoraria for consultancy/advisory role and/or for lectures from: Bayer, Blueprint Medicines, Deciphera Pharmaceuticals, Eisai, Eli Lilly, Nektar Ther., Novartis, Pfizer, PharmaMar. At his institution, his Unit received funds for research from: AmgenDompé, Arog Pharmaceuticals, Bayer, Eisai, Eli Lilly, Daiichi Sankyo Pharma, Epizyme Inc., Novartis, PharmaMar. MS: Conducts research sponsored by Janssen Pharmaceuticals. Advisory Boards: BMS, Novartis, Janssen Pharmaceuticals, Leo Pharma. Speaker bureau for BMA, Novartis. Travel funding: Novartis, BMS, Astellas, Ipsen. All other authors declare no competing interests related to this paper.

Figures

Figure 1
Figure 1
The six building blocks of a health system that must be considered for effective, comprehensive delivery of cancer services. Taken from: Everybody’s business—strengthening health systems to improve health outcomes.
Figure 2
Figure 2
Three dimensions to consider when moving towards universal coverage.
Figure 3
Figure 3
Process of quality improvement, roles and responsibilities. Taken from WHO Quality of Care: A Process for Making Strategic Choices In Health Systems.
See this image and copyright information in PMC

References

    1. Global health observatory: the data repository. Geneva: World Health Organization, 2017. (accessed 1 Jun 2017).
    1. Ferlay J, Soerjomataram I, Ervik M, et al. . GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer, 2013. (accessed 1 Jun 2017).
    1. Farmer P, Frenk J, Knaul FM, et al. . Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010;376:1186–93. 10.1016/S0140-6736(10)61152-X - DOI - PubMed
    1. Open database: IHME. http://www.healthdata.org/data-visualization/financing-global-health
    1. Medicines Use and Spending in the U.S.A Review of 2016 and Outlook to 2021. https://www.iqvia.com/institute/reports/medicines-use-and-spending-in-th....